Revolution Medicines is an innovative and dynamic organization of expert scientists and business executives working together to discover and develop new medicines for cancer patients against frontier oncology targets. Frontier oncology targets are proteins that drive the growth of cancers or that control immune responses that can defeat them. Frontier targets have not been drugged successfully before or have been inadequately served by previous drug discovery efforts. The current discovery programs are focused in two areas, our Phosphatase and Beyond Rule of 5 (bRo5) Platforms.